期刊文献+

乳腺癌放疗联合曲妥珠单抗的心脏毒性与保护研究进展 被引量:1

原文传递
导出
摘要 15%-25%的乳腺癌患者存在HER-2基因扩增或过表达[1]。作为拮抗HER-2胞外受体的人源化单克隆抗体,曲妥珠单抗辅助治疗经5项随机对照临床试验证实可显著提高HER-2阳性乳腺癌患者的总生存(RR=0.66)及无瘤生存(RR=0.62)[2]。心脏毒性是曲妥珠单抗的主要不良反应,4.3%~17.3%的患者因此中断治疗[3]。
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2013年第1期84-86,共3页 Chinese Journal of Radiation Oncology
  • 相关文献

参考文献44

  • 1Smith I, Procter M, Gelber RD, et al. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled triM. Lancet,2007,369:29-36.
  • 2Dahabreh IJ, Linardou H, Siannis F, et al. Trastuzumab in the adjuvant treatment of early-stage breast cancer: a systematic review and recta-analysis of randomized controlled trials. Oncologist, 2008,13:620-630.
  • 3Di Cosimo S. Heart to heart with trastuzumab: a review on cardiac toxicity. Target Oncol,2011,6 : 189-195.
  • 4Clarke M,Collins R,Darby S,et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet ,2005,366:2087-2106.
  • 5Liang K,Lu Y,Jin W,et al. Sensitization of breast cancer cells to radiation by trastuzumab. Mol Cancer Ther,2003,2 : 1113 - 1120.
  • 6Horton JK, Halle J, Ferraro M, et al. Radiosensitization of chemotherapy-refractory, locally advanced or locally recurrent breast cancer with trastnzumab: a phase Ⅱ trial. Int J Radiat Oncol Biol Phys,2010,76:998-1004.
  • 7Negro A, Brar BK, Lee KF. Essential roles of HER-2/erbB2 in cardiac development and function. Recent Prog Horm Res,2004, 59:1-12.
  • 8Crone SA, Zhao YY, Fan L, et al. ErbB2 is essential in the prevention of dilated eardiomyopathy. Nat Meal,2002,8:459-465.
  • 9Lemmens K, Doggen K, De Keulenaer GW. Role of Neuregulin-1/ ErbB signaling in cardiovascular physiology and disease : implications for therapy of heart failure. Circulation, 2007,116 : 954-960.
  • 10Uray IP, Connelly JH, Thomazy V, et al. Left ventricular unloading alters receptor tyrosine kinase expression in the failing human heart. J Heart Lung Transplant,2002,21:771-782.

二级参考文献42

  • 1顾文栋,冯炎.放射线诱发心脏损伤的病理学机制[J].中华放射肿瘤学杂志,2004,13(2):110-112. 被引量:13
  • 2Marks LB, Yu X, Prosnitz RG, et al. The incidence and functional consequences of RT-associated cardiac perfusion defects, Int J Radiat Oncol Biol Phys,2005,63:214-223.
  • 3Gyenes G, Fornander T, Carlens P, et al. Morbidity of ischemic heart disease in early breast cancer 15 - 20 years after adjuvantradiotherapy. Int J Radiat Oncol Biol Phys,1994,28:1235-1241.
  • 4Gustavsson A, Bendahl P, Cwikiel M, et al. ,No serious late eardiae effects after adjuvant radiotherapy following masteetomy in premenopausal women with early breast eaneer. Int J Radiat Oneol Biol Phys, 1999,43:745-754.
  • 5Breast cancer atlas for radiation therapy planning: consensus definitions [2010-06-10]. http://www, rtog. org/At|ases/ breastCancer/main, html.
  • 6Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy : guidelines of the American Society of Clinical Oncology. J Clin Onco,2001,19 : 1539-1569.
  • 7NCCN Clinical Practice Guidelines in Oncology: Breast Cancer [2010-06-20]. http://www, nccn. org/professionals/physician gls/PDF/breast, pdf.
  • 8Marks LB, Hebert ME, Bentel G, et al. To treat or not to treat the internal mammary nodes: a possible compromise. Int J Radiat Oncol Bi01 Phys, 1994,29:903-909.
  • 9van der Laan HP, Dolsma WV, van't Veld AA, et al. Comparison of normal tissue dose with three-dimensional conformal techniques for breast cancer irradiation including the internal mammary nodes. Int J Radiat Oncol Biol Phys,2005,63:1522-1530.
  • 10Pierce LJ, Butler JB, Martel MK, et al. Postmastectomy radiotherapy of the chest wall: Dosimetric comparison of common techniques. Int J Radiat Oncol Biol Phys ,2002 ,52 : 1220-1230.

共引文献45

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部